The characteristics of association studies of polymorphisms in ARRB2 and response to opioids for pain management in advanced cancer, categorized as high/low pain scores or high/low fentanyl dose requirements, are again shown in Tables 6 and 7. This evidence concerns the gene ARRB2 and cancer.